Comparación entre artritis reumatoide seronegativa y artritis psoriásica poliarticular: estudio transversal en una cohorte brasileña
Resumen
Objetivos: comparar el riesgo cardiovascular, la calidad de vida, la depresión y la funcionalidad entre pacientes con artritis reumatoide (AR) seronegativa y artritis psoriásica (APs) poliarticular. Materiales y métodos: se analizaron datos de 45 pacientes con AR seronegativa y 36 con APs poliarticular. Se utilizaron cuestionarios para depresión (CES-D), funcionalidad (Health Assessment Questionnaire, HAQ) y calidad de vida (SF-12). Se midió el espesor íntima-media carotídea (cIMT) para valorar riesgo cardiovascular. Resultados: las frecuencias de hipertensión, diabetes y dislipidemia fueron similares entre ambos grupos. Los pacientes con APs tenían un índice de masa corporal (IMC) y circunferencia abdominal más altos. El cIMT fue equivalente entre los grupos. La depresión y calidad de vida no mostraron diferencias significativas. Los pacientes con AR presentaron peor funcionalidad según el HAQ. Conclusiones: en nuestra serie los pacientes con AR y APs seronegativos tuvieron similitudes en calidad de vida, depresión y riesgo cardiovascular, excepto por diferencias en IMC y circunferencia abdominal, más altos en APs. La funcionalidad fue peor en AR en comparación con APs.Citas
I. Grellmann C, Dombrowsky W, Fabricius V, Suruki R, Sheahan A, Joeres L. Epidemiology, and treatment of patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis in Germany: A real-world evidence study. Adv Ther 2021;38(1):366-385. doi: 10.1007/s12325-020-01522-8.
II. Merola JF, Espinoza LR, Fleischmann R. Distinguishing rheumatoid arthritis from psoriatic arthritis. RMD Open 2018; 4(2): e000656. doi: 10.1136/rmdopen-2018-000656. eCollection 2018.
III. Fragoulis GE, Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S, Konstantonis G, et al. Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther Adv Musculoskelet Dis. 2020; 12:1759720X20976975. doi: 10.1177/1759720X20976975.
IV. González-Martin C, Grande Morais S, Pertega-Diaz S, Seoane-Pillado T, Balboa-Barreiro V, Veiga-Seijo R. Concordance between the different cardiovascular risk scores in people with rheumatoid arthritis and psoriasis arthritis. Cardiol Res Pract 2019; 2019:7689208. doi: 10.1155/2019/7689208. eCollection 2019.
V. Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014; 66(4):600-7. doi: 10.1002/acr.22185.
VI. Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg JD, Kremer JM, et al. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. J Rheumatol 2010; 37(12):2566-72. doi: 10.3899/jrheum.100483.
VII. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81. doi: 10.1002/art.27584.
VIII. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54(8): 2665-73. doi: 10.1002/art.21972.
IX. Silveira DJ; Jorge MR. Psychometric properties of the Epidemiologic Screening Scale for Depression (CES-D) in clinical and non-clinical populations of adolescents and young adults. Rev Psiquiatr Clin (São Paulo) 1998; 25(5):251-61. doi: 10.1590/1516-4446-2012-0875.
X. Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P. Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 1990; 17(6):813-7. PMID: 2388204.
XI. Andrade TL, Camelier AA, Rosa FW, Santos MP, Jezler S, Pereira e Silva JL. Applicability of the 12-Item Short-Form Health Survey in patients with progressive systemic sclerosis. J Bras Pneumol 2007; 33:414-22. doi: 10.1590/s1806-37132007000400010.
XII. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011 Cerebrovasc Dis 2012; 34:290–6. doi: 10.1159/000343145.
XIII. Toborek M, Kaiser S. Endothelial cell function: relationship to atherogenesis. Basic Res Cardiol 1999;94:295-314. doi: 10.1007/s003950050156.
XIV. Kubrusly M, Oliveira CM, Simões PS, Lima R de O, Galdino PN, Sousa P de A, et al. Prevalence of metabolic syndrome according to NCEP-ATP III and IDF criteria in patients on hemodialysis. J Bras Nefrol 2015: 37(1):72-8. doi: 10.5935/0101-2800.20150011.
XV. Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg JD, Kremer JM, et al. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. J Rheumatol 2010; 37(12):2566-72. doi: 10.3899/jrheum.100483.
XVI. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Arch Intern Med 2007; 167:1670-5. doi: 10.1001/archinte.167.15.1670.
XVII. Li B, Huang H, Zhao J, Deng X, Zhang Z. Discrepancy in metabolic syndrome between psoriatic arthritis and rheumatoid arthritis: a direct comparison of two cohorts in one center. Rheumatol Ther 2022 Oct 20. doi: 10.1007/s40744-022-00502-4.
XVIII. de Menezes Ettinger JE, Azaro E, de Souza CA, dos Santos Filho PV, Mello CA, Neves M Jr, et al. Remission of psoriasis after open gastric bypass. Obes Surg 2006; 16:94-7. doi: 10.1381/096089206775221998.
XIX. Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 2017;76 (11): 1906-1910. doi: 10.1136/annrheumdis-2017-211284.
XX. Fragoulis GE, Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S, Konstantonis G, et al Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther Adv Musculoskelet Dis 2020;12:1759720X20976975. doi: 10.1177/1759720X20976975.
XXI. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113(9):1271-6. doi: 10.1172/JCI20945.
XXII. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28(8):1842-6. PMID: 11508587.
XXIII. Gregoire ARF, DeRuyter BK, Stratman EJ. Psoriasis flares following systemic glucocorticoid exposure in patients with a history of psoriasis. JAMA Dermatol 2021; 157(2):198-201. doi: 10.1001/jamadermatol.2020.4219.
Derechos de autor 2024 a nombre de los autores. Derechos de reproducción: Sociedad Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
